« ALEA Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next

Re: Trump Has Financial Interest in Hydroxychloroquine Manufacturer: NYT

By: Cactus Flower in ALEA | Recommend this post (0)
Tue, 07 Apr 20 3:03 PM | 38 view(s)
Boardmark this board | The Trust Matrix
Msg. 35321 of 54959
(This msg. is a reply to 35319 by clo)

Jump:
Jump to board:
Jump to msg. #

Before getting too outraged, I'd be interested in two things:

1. Whether his investment in Sanofi represents a disproportionate share of Trump's total holdings.

2. Since the mutual funds are not run by Trump, and as far as I am aware they don't report their holdings every day, did he actually know they were invested in Sanofi?

In this case, you have to be careful that the journalists may be making the story conform with their suspicions. They may be motivated by the splash.


- - - - -
View Replies (1) »



» You can also:
- - - - -
The above is a reply to the following message:
Trump Has ‘Financial Interest’ in Hydroxychloroquine Manufacturer: NYT
By: clo
in ALEA
Tue, 07 Apr 20 2:21 PM
Msg. 35319 of 54959

Trump Has ‘Financial Interest’ in Hydroxychloroquine Manufacturer: NYT
THERE IT IS

Justin Baragona Contributing Editor
Updated Apr. 07, 2020 4:10

President Donald Trump has a “small financial interest” in the maker of an anti-malarial drug that he has been touting as a “game changer” in treating coronavirus, according to The New York Times. Over the past two weeks, Trump and his Fox News allies have aggressively promoted hydroxychloroquine as a potential cure, despite top infectious-disease expert Dr. Anthony Fauci and others urging caution and noting that there was not enough evidence of the drug’s efficacy.

The Times reports the president’s family trusts all have investments in a mutual fund whose largest holding is Sanofi, the manufacturer of Plaquenil, the brand-name version of hydroxychloroquine. Associates of the president, including Commerce Secretary Wilbur Ross, have also run funds that hold investments in the pharmaceutical firm.

Read it at The New York Times


« ALEA Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next